Volume 48, Number 6, 524-529, DOI: 10.1007/s10384-004-0129-0

Published in partnership with the

Logo

Japanese Ophthalmological Society

Ki-67 Labeling Index as a Marker of Malignancy in Ocular Surface Neoplasms

Maki Ohara, Chie Sotozono, Yasunari Tsuchihashi and Shigeru Kinoshita

View Related Documents

Abstract

Purpose  

To evaluate the relationships among histopathological type, clinical malignant grade, and Ki-67 labeling index (LI) in sebaceous gland carcinoma (SGC), conjunctival squamous cell carcinoma (SCC), and conjunctival intraepithelial neoplasia (CIN), with pterygium and normal conjunctiva as controls.

Methods  

This retrospective study was conducted at the Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. We used tissue specimens obtained from 20 patients (four SGC, four SCC, four CIN, four pterygium, and four normal conjunctiva). Ki-67 immunohistochemical analysis was performed in all 20 cases.

Results  

The Ki-67 labeling index (LI) was 46.1 ± 3.0% (average ± SD) in SGC, 28.4 ± 4.5% in SCC, 20.0 ± 7.2% in CIN, 9.0 ± 2.2% in pterygium, and 6.8 ± 2.3% in normal conjunctiva. Ki-67 LI was significantly (Mann-Whitney U test, P < 0.05) higher in SGC than in SCC, and higher, but not significantly, in SCC than in CIN. Ki-67 LI was significantly (P < 0.05) higher in SCC and CIN than in pterygium.

Conclusions  

These results suggest that Ki-67 LI may be a sensitive marker for ocular malignant tumor grading. Jpn J Ophthalmol 2004;48:524–529 © Japanese Ophthalmological Society 2004

Key words  conjunctival intraepithelial neoplasia - conjunctival squamous cell carcinoma - Ki-67 labeling index - sebaceous gland carcinoma - 5-fluorouracil

Fulltext Preview

Image of the first page of the fulltext document